Related Insights
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Blog
Preparing for the New Era of Hybrid Regulatory Inspections
Jul 11, 2022
Video
On-demand webinar: An expert guide to EU-CTR
Mar 10, 2022
Blog
Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence
Apr 4, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022